Mary Ann Chapman

748 total citations
23 papers, 565 citations indexed

About

Mary Ann Chapman is a scholar working on Cellular and Molecular Neuroscience, Neurology and Physiology. According to data from OpenAlex, Mary Ann Chapman has authored 23 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Neurology and 8 papers in Physiology. Recurrent topics in Mary Ann Chapman's work include Neuroscience and Neuropharmacology Research (6 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Mary Ann Chapman is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Mary Ann Chapman collaborates with scholars based in United States, Germany and Canada. Mary Ann Chapman's co-authors include Ronald E. See, Geoffrey C. Gurtner, David Charles, Michelle Harvie, Anthony Howell, Charles K. Meshul, Susan Abushakra, Jean Carruthers, Ross Zafonte and Frederick C. Beddingfield and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and European Journal of Pharmacology.

In The Last Decade

Mary Ann Chapman

22 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ann Chapman United States 13 237 205 108 102 68 23 565
Xu‐Hong Gu United Kingdom 8 61 0.3× 174 0.8× 169 1.6× 93 0.9× 58 0.9× 9 439
Magdalena Lang United States 11 122 0.5× 64 0.3× 184 1.7× 54 0.5× 32 0.5× 25 517
Hanna‐Stiina Taskinen Finland 10 76 0.3× 331 1.6× 156 1.4× 68 0.7× 83 1.2× 18 477
Hyun Joon Lee United States 16 90 0.4× 246 1.2× 121 1.1× 168 1.6× 51 0.8× 33 697
Luitpold E. Miller Germany 8 43 0.2× 200 1.0× 116 1.1× 141 1.4× 36 0.5× 8 574
Els K. Vanhoutte Netherlands 10 164 0.7× 180 0.9× 300 2.8× 278 2.7× 18 0.3× 17 639
M A Tuveri Italy 6 36 0.2× 268 1.3× 176 1.6× 67 0.7× 23 0.3× 8 457
Sebastian Stösser Germany 8 42 0.2× 132 0.6× 233 2.2× 106 1.0× 33 0.5× 20 497
Mark A. Oatway Canada 8 95 0.4× 283 1.4× 244 2.3× 93 0.9× 124 1.8× 10 704
Ivica Matak Croatia 14 839 3.5× 220 1.1× 574 5.3× 57 0.6× 44 0.6× 31 1.0k

Countries citing papers authored by Mary Ann Chapman

Since Specialization
Citations

This map shows the geographic impact of Mary Ann Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Chapman more than expected).

Fields of papers citing papers by Mary Ann Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Chapman. The network helps show where Mary Ann Chapman may publish in the future.

Co-authorship network of co-authors of Mary Ann Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Chapman. A scholar is included among the top collaborators of Mary Ann Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Chapman. Mary Ann Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brin, Mitchell F., et al.. (2024). Versatility of OnabotulinumtoxinA in Aesthetic Medicine. Dermatologic Surgery. 50(9S). S12–S17. 1 indexed citations
2.
Struthers, Allan D., et al.. (2024). Utilization Management and Physician Burnout. The American Journal of Managed Care. 30(11). 561–566.
3.
Gurtner, Geoffrey C. & Mary Ann Chapman. (2015). Regenerative Medicine: Charting a New Course in Wound Healing. Advances in Wound Care. 5(7). 314–328. 64 indexed citations
4.
Chapman, Mary Ann. (2014). Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson’s disease. Medical Hypotheses. 83(2). 203–207. 18 indexed citations
5.
Chapman, Mary Ann, et al.. (2013). Five-Year Weight Loss Experience of Outpatients Receiving Laparoscopic Adjustable Gastric Band Surgery. Obesity Surgery. 23(7). 903–910. 19 indexed citations
6.
Rancati, Alberto, et al.. (2013). The South American Glabellar Experience Study (SAGE). Aesthetic Surgery Journal. 33(7). 1039–1045. 12 indexed citations
7.
Moers-Carpi, Marion, Thomas Dirschka, Said Hilton, et al.. (2012). A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines. Journal of Cosmetic and Laser Therapy. 14(6). 296–303. 21 indexed citations
8.
Naumann, Markus, Alastair Carruthers, Jean Carruthers, et al.. (2010). Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Movement Disorders. 25(13). 2211–2218. 109 indexed citations
9.
Chapman, Mary Ann, et al.. (2010). Laparoscopic Gastric Banding Is Safe in Outpatient Surgical Centers. Obesity Surgery. 20(4). 415–422. 31 indexed citations
10.
Ong, Kai Ren, Andrew H. Sims, Michelle Harvie, et al.. (2009). Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer. Cancer Prevention Research. 2(8). 720–731. 39 indexed citations
11.
Chapman, Mary Ann. (2009). Does smoking reduce the risk of Parkinson’s disease through stimulation of the ubiquitin–proteasome system?. Medical Hypotheses. 73(6). 887–891. 6 indexed citations
12.
Howell, Anthony, Mary Ann Chapman, & Michelle Harvie. (2008). Energy Restriction for Breast Cancer Prevention. Recent results in cancer research. 181. 97–111. 23 indexed citations
13.
Chapman, Mary Ann, et al.. (2007). Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia. Clinical Therapeutics. 29(7). 1325–1337. 41 indexed citations
14.
Chapman, Mary Ann, John M. Roll, Samuel Park, & Matthew P. Galloway. (2003). Extracellular glutamate decrease in accumbens following cued food delivery. Neuroreport. 14(7). 991–994. 1 indexed citations
15.
Grimm, Jeffrey W., Mary Ann Chapman, Daniel S. Zahm, & Ronald E. See. (2000). Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats. Synapse. 39(1). 51–57. 25 indexed citations
16.
See, Ronald E. & Mary Ann Chapman. (1994). Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. European Journal of Pharmacology. 263(3). 269–276. 70 indexed citations
17.
See, Ronald E., Leah E. Adams‐Curtis, & Mary Ann Chapman. (1992). Assessment of Dopamine Release by in Vivo Microdialysis in the Nucleus Accumbens of Rats following Acute and Chronic Administration of Desipraminea. Annals of the New York Academy of Sciences. 654(1). 522–524. 5 indexed citations
18.
See, Ronald E., Mary Ann Chapman, & Charles K. Meshul. (1992). Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse. 12(2). 147–154. 28 indexed citations
19.
See, Ronald E., et al.. (1992). Regional differences in chronic neuroleptic effects on extracellular dopamine activity. Brain Research Bulletin. 29(3-4). 473–478. 23 indexed citations
20.
See, Ronald E. & Mary Ann Chapman. (1991). Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacology Biochemistry and Behavior. 39(1). 49–54. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu‐Hong Gu Breakdown of academic impact, for papers by Magdalena Lang Breakdown of academic impact, for papers by Hanna‐Stiina Taskinen Breakdown of academic impact, for papers by Hyun Joon Lee Breakdown of academic impact, for papers by Luitpold E. Miller Breakdown of academic impact, for papers by Els K. Vanhoutte Breakdown of academic impact, for papers by M A Tuveri Breakdown of academic impact, for papers by Sebastian Stösser Breakdown of academic impact, for papers by Mark A. Oatway Breakdown of academic impact, for papers by Ivica Matak
Rankless by CCL
2026